Medifast (NYSE: MED) reported Q4 EPS of $3.70, $1.48 better than the analyst estimate of $2.22. Revenue for the quarter came in at $337.2 million versus the consensus estimate of $330.1 million.

For earnings history and earnings-related data on Medifast (MED) click here.